Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2018; 12(03): 358-362
DOI: 10.4103/ejd.ejd_342_17
Original Article
Dental Investigation Society

A potential therapy of human umbilical cord mesenchymal stem cells for bone regeneration on osteoporotic mandibular bone

Nike Hendrijantini
1   Department of Prosthodontic, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Tuti Kusumaningsih
2   Department of Oral Biology, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Rostiny Rostiny
1   Department of Prosthodontic, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Pungky Mulawardhana
3   Department of Obstetrics and Gynecology, Medical Faculty, Universitas Airlangga, Surabaya, Indonesia
4   Department of Obstetrics and Gynecology, Dr. Soetomo Hospital, Surabaya, Indonesia
,
Coen Pramono Danudiningrat
5   Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Fedik Abdul Rantam
6   Department of Microbiology and Virology, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia
› Author Affiliations
Further Information

Publication History

Publication Date:
16 September 2019 (online)

Also available at
   Permissions and Reprints

ABSTRACT

Objective: The aim of this study is to prove that human umbilical cord mesenchymal stem cell (hUCMSC) therapy on mandibular osteoporotic model is able to increase transforming growth factor-beta-1 (TGF)-β1 expression, Runx2, and osteoblasts. Materials and Methods: This research is true experimental posttest control group design. Thirty female Wistar rats were divided into 6 groups randomly, which consisted of sham surgery for control (T1), ovariectomy as osteoporotic group (T2), osteoporotic group injected with gelatine for 4 weeks (T3), 8 weeks (T4) injected with hUCMSC-gelatine for 4 weeks (T5) and 8 weeks (T6). All mice were presented for immunohistochemistry examination for TGF-β1, Runx2, and histology for osteoblasts. Results: The lowest level of osteoblast was osteoporotic group injected with gelatine in 4 weeks compared to other groups. There were increases of TGF-β1, Runx2, and osteoblasts from osteoporotic group compared to osteoporotic post-hUCMSC-gelatine injection group. Conclusion: The hUCMSC has a high osteogenic effect and increases the osteoporotic mandibular bone regeneration on the animal model that is showed by the increase of the level of TGF-β1, Runx2, and osteoblasts.

Key words:

Human umbilical cord mesenchymal stem cells - mandibular - osteoporosis
 

  • REFERENCES

  • 1 Misch CE. Rationale for dental implants. Contemporary Implant Dentistry 3rd ed.. St. Louis, Canada: Mosby Inc.; 2008: 3-21
    Google Scholar
  • 2 Guyton AC, Hall JE. Text Book of Medical Physiology. 12th ed.. Philadelphia: Saunders: Elsevier; 2011: 1070-6
    Google Scholar
  • 3 Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: An exploratory case-control study. J Periodontol 2000; 71: 625-31
    CrossrefPubMedGoogle Scholar
  • 4 Wang Z, Goh J, Das De S, Ge Z, Ouyang H, Chong JS. et al Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 2006; 12: 1753-61
    CrossrefPubMedGoogle Scholar
  • 5 Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy. Cell Transplant 2015; 24: 339-47
    CrossrefPubMedGoogle Scholar
  • 6 Kasagi S, Chen W. TGF-beta1 on osteoimmunology and the bone component cells. Cell Biosci 2013; 3: 4
    CrossrefPubMedGoogle Scholar
  • 7 Abbas AK, Lichtman AW, Pillai S. Cellular and Molecular Immunology. Philadephia: Elsevier Saunders; 2017: 266-70
    Google Scholar
  • 8 Siddiqui S, Arshad M. Osteogenic potential of punica granatum through matrix mineralization, cell cycle progression and Runx-2 gene expression in primary rat osteoblasts. Daru 2014; 22: 72
    CrossrefPubMedGoogle Scholar
  • 9 Khajuria D, Razdan R, Mahapatra D. Description of a New Method of Ovariectomy in Female Rats. 14th ed.. Bangalore: Springer; 2012
    Google Scholar
  • 10 Han YF, Tao R, Sun TJ, Chai JK, Xu G, Liu J. et al Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology 2013; 65: 819-27
    CrossrefPubMedGoogle Scholar
  • 11 Hendrijantini N, Kresnoadi U, Salim S, Agustono B, Retnowati E, Syahrial I. et al Study biocompatibility and osteogenic differentiation potential of human umbilical cord mesenchymal stem cells (hUCMSCs) with gelatin solvent. J Biomed Sci Eng 2015; 8: 420-8
    CrossrefGoogle Scholar
  • 12 Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. et al Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996; 2: 1132-6
    CrossrefPubMedGoogle Scholar
  • 13 Marie PJ, Kassem M. Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets. Eur J Endocrinol 2011; 165: 1-0
    CrossrefPubMedGoogle Scholar
  • 14 Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF. Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 2003; 32: 297-310
    CrossrefPubMedGoogle Scholar
  • 15 Pino AM, Rosen CJ, Rodríguez JP. In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol Res 2012; 45: 279-87
    Google Scholar
  • 16 Prall WC, Haasters F, Heggebö J, Polzer H, Schwarz C, Gassner C. et al Mesenchymal stem cells from osteoporotic patients feature impaired signal transduction but sustained osteoinduction in response to BMP-2 stimulation. Biochem Biophys Res Commun 2013; 440: 617-22
    CrossrefPubMedGoogle Scholar
  • 17 Li C, Wei G, Gu Q, Wang Q, Tao S, Xu L. et al Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection. Med Sci Monit 2015; 21: 845-54
    CrossrefPubMedGoogle Scholar
  • 18 Ma L, Aijima R, Hoshino Y, Yamaza H, Tomoda E, Tanaka Y. et al Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice. Stem Cell Res Ther 2015; 6: 104
    CrossrefPubMedGoogle Scholar
  • 19 Kini U, Nandeesh BN. Physiology of bone formation, remodeling, and metabolism. Fogelman I, Gnanasegaran G, Van der Wall H. Radionuclide and Hybrid Bone Imaging Berlin: Springer; 2012: 29-57
    Google Scholar
  • 20 Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272-88
    CrossrefPubMedGoogle Scholar
  • 21 Garrett I. Anabolic agents and the bone morphogenic protein pathway in current topics in developmental biology. San Antonio: Elsevier Inc.; 2007
    Google Scholar